122 related articles for article (PubMed ID: 11464464)
1. [Roles of mitochondrial dysfunctions in Alzheimer's disease--contribution of deficiency of ALDH 2].
Ohta S
Rinsho Shinkeigaku; 2000 Dec; 40(12):1231-3. PubMed ID: 11464464
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ALDH2 deficiency as an oxidative stress.
Ohta S; Ohsawa I; Kamino K; Ando F; Shimokata H
Ann N Y Acad Sci; 2004 Apr; 1011():36-44. PubMed ID: 15126281
[TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].
Shimada K; Yasuda M; Maeda K
Seishin Shinkeigaku Zasshi; 1997; 99(8):575-87. PubMed ID: 9369084
[TBL] [Abstract][Full Text] [Related]
5. The association of mitochondrial aldehyde dehydrogenase gene (ALDH2) polymorphism with susceptibility to late-onset Alzheimer's disease in Chinese.
Wang B; Wang J; Zhou S; Tan S; He X; Yang Z; Xie YC; Li S; Zheng C; Ma X
J Neurol Sci; 2008 May; 268(1-2):172-5. PubMed ID: 18201725
[TBL] [Abstract][Full Text] [Related]
6. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
[TBL] [Abstract][Full Text] [Related]
9. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
[TBL] [Abstract][Full Text] [Related]
10. Is ApoE gene a risk factor for vascular dementia in Han Chinese?
Yang J; Feng G; Zhang J; Hui Z; Breen G; St Clair D; He L
Int J Mol Med; 2001 Feb; 7(2):217-9. PubMed ID: 11172628
[TBL] [Abstract][Full Text] [Related]
11. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
12. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
13. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
[TBL] [Abstract][Full Text] [Related]
15. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.
González C; Martín T; Cacho J; Breñas MT; Arroyo T; García-Berrocal B; Navajo JA; González-Buitrago JM
Eur J Clin Invest; 1999 Jul; 29(7):637-42. PubMed ID: 10411671
[TBL] [Abstract][Full Text] [Related]
16. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.
Arendt T; Schindler C; Brückner MK; Eschrich K; Bigl V; Zedlick D; Marcova L
J Neurosci; 1997 Jan; 17(2):516-29. PubMed ID: 8987775
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan.
Nunomura A; Chiba S; Eto M; Saito M; Makino I; Miyagishi T
Neurosci Lett; 1996 Mar; 206(1):17-20. PubMed ID: 8848271
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E: risk factor for Alzheimer disease.
Tsai MS; Tangalos EG; Petersen RC; Smith GE; Schaid DJ; Kokmen E; Ivnik RJ; Thibodeau SN
Am J Hum Genet; 1994 Apr; 54(4):643-9. PubMed ID: 8128961
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.
Panza F; Solfrizzi V; Torres F; Mastroianni F; Colacicco AM; Basile AM; Capurso C; D'Introno A; Del Parigi A; Capurso A
Neurosci Lett; 2000 Oct; 292(2):79-82. PubMed ID: 10998553
[TBL] [Abstract][Full Text] [Related]
20. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
